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0022-2836 © 2012 Elsevier Ltd. Open accThe core shell of hepatitis B virus is a potent immune stimulator, giving a
strong neutralizing immune response to foreign epitopes inserted at the
immunodominant region, located at the tips of spikes on the exterior of the
shell. Here, we analyze structures of core shells with a model epitope
inserted at two alternative positions in the immunodominant region.
Recombinantly expressed core protein assembles into T=3 and T=4
icosahedral shells, and atomic coordinates are available for the T=4 shell.
Since the modiﬁed protein assembles predominantly into T=3 shells, a
quasi-atomic model of the native T=3 shell was made. The spikes in this
T=3 structure resemble those in T=4 shells crystallized from expressed
protein. However, the spikes in the modiﬁed shells exhibit an altered
conformation, similar to the DNA containing shells in virions. Both
constructs allow full access of antibodies to the foreign epitope, DPAFR
from the preS1 region of hepatitis B virus surface antigen. However, one
induces a 10-fold weaker immune response when injected into mice. In this
construct, the epitope is less constrained by the ﬂanking linker regions and
is positioned so that the symmetry of the shell causes pairs of epitopes to
come close enough to interfere with one another. In the other construct, the
epitope mimics the native epitope conformation and position. The
interaction of native core shells with an antibody speciﬁc to the
immunodominant epitope is compared to the constructs with an antibody
against the foreign epitope. Our ﬁndings have implications for the design of
vaccines based on virus-like particles.© 2012 Elsevier Ltd. Open access under CC BY license.ife Sciences,
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The core protein of hepatitis B virus (HBV)
provides an appropriate framework for display of
foreign epitopes and has been suggested to provide
a basis for novel vaccines.1–3 Core shells expressing
part of the foot and mouth disease virus capsid gave
protective immunity to virus challenge in guinea
pigs.4 Clinical trials are in progress for a malaria
vaccine based on a core protein displaying B- and T-
cell epitopes from the circumsporozoite surface
protein.5–7 A segment of the inﬂuenza virus M2
protein by display on core was rendered strongly.
64 Structures of HBV Cores Presenting a Model Epitopeimmunogenic and protective in mice.8 It is even
possible to display whole domains, for example, the
28‐kDa ectodomain of the OspA (outer surface
protein A) of the Lyme disease agent, where the
resulting construct conferred immunity to the agent
in mice.9 The utility of the core shell arises in part
from the special properties it has in stimulating
different aspects of the immune system.10
The recombinant core protein can be readily
expressed in Escherichia coli, where it assembles
into icosahedral shells of two sizes, containing 180
(T=3) or 240 (T=4) subunits, respectively.11 Hepa-
titis B virions contain the T=4 form of the core
shell.12 The core protein has a basic C-terminal tail
that interacts with and packages nucleic acid but
that is dispensable for shell formation, provided the
truncation is not before amino acid 140.13–15 The
position of the truncation inﬂuences the ratio of T=3
to T=4 particles.16 The fold of the core protein was
determined by electron cryomicroscopy17 and an
atomic structure of the T=4 shell was solved by X-
ray crystallography.18 The shells are built from
dimers of core protein molecules, with each dimer
producing a spike on the surface consisting of a four-
helix bundle formed by apposed α-helical hairpins
(Fig. 1).17–19 During assembly of the virion, the core
undergoes a maturation step involving a relative
scissor-like movement of the α-helical hairpins,
which enables envelopment of the core and secre-
tion of the virus.12
The core protein can remain assembly competent
while accommodating foreign inserts at the N- and
C-termini and more importantly at the tips of the
spikes, where the immunodominant epitope of the
native core protein is located. The tip itself has a large
insertion capacity, accepting, for example, a 120‐
amino‐acid hantavirus nucleocapsid fragment,20 the
entire green ﬂuorescent protein (238 aa),21 or a
domain of the Lyme disease OspA outer protein
(255 aa).9 For short peptides, display on the core
protein greatly increases the immunogenicity of the
foreign protein segment.4,22 Moreover, insertion in
the context of the helical hairpin forming the spike is
likely to constrain the conformation of an inserted
peptide.23
The epitopes of the native core structure have been
extensively investigated by using electron micros-
copy (EM) to examine complexes of core shells with
various antibodies.24–27 However, no detailed struc-
tural analysis has been made of the display of
foreign epitopes and their complexes with anti-
bodies. We here describe the structures determined
by electron cryomicroscopy of engineered core
shells displaying at the spike tip a well-character-
ized epitope DPAFR from the preS1 region of the
surface protein of HBV,28,29 against which a speciﬁc
monoclonal antibody MA18/7 is available.30 More
precise mapping revealed a DPxF sequence as a
necessary and sufﬁcient epitope for the antibodyrecognition.31 This antibody inhibits attachment of
HBV to human hepatocytes32 and blocks model
infection of primary Tupaia hepatocytes.33 More-
over, the DPAFR epitope is structurally similar to
the native immunodominant DPASR/DPISR stretch
at the tip of the core spike. We examined two
constructs, which position the foreign epitope
differently. The insertions result in an increased
ratio of T=3 to T=4 particles. Besides showing local
differences at the spike tips when comparedwith the
native protein, the construct maps show bodily
rotation of the core protein molecules, similar to
those seen in maturation of the core shell,12 and not
unexpected as the shell is known to react to
conformational stress.34 We compared antibody
complexes of the two constructs with the native
structure in complex with an antibody against the
immunodominant native epitope. The results dem-
onstrate that the different insertions result in a
different geometry of antibody interactions with
varying degrees of steric hindrance between anti-
body fragments on neighboring epitopes. Under-
standing the changes in shell structure caused by
insertions and the overall geometry of the antibody
complexes may help to deﬁne the most efﬁcient
ways of displaying foreign epitopes to produce
effective vaccines.Results and Discussion
The native T=3 core shell structure
The structure of the T=4 form of the core shell is
shown in Fig. 1a, with a detailed view of the α-
helical hairpins forming the spike in Fig. 1b and
c.17,18 The nomenclature16 for the subunits in the
T=4 and T=3 shells is shown in Fig. 1d and e. In the
T=4 shell, there are A,B and C,D dimers formed by
the four computationally nonequivalent subunits. In
the T=3 shell, the dimers are of the form A,B and C,
C, with the C,C dimers lying on strict 2-fold axes.
The assembly of the core protein into T=3 or
T=4 sized shells is inﬂuenced by truncation of the
core protein at different points near the C‐terminus
and by modiﬁcations elsewhere.16,34 Since the
proportion of T=3 particles increased markedly
with insertions into the major immunodominant
region (MIR) at the tip of the spike (Table 1), we
needed a detailed model of the native T=3 form of
the shell, as a basis to understand the changes in
the shells with insertions. Using a construct
truncated at position 140, which forms mainly
T=3 core shells (75%), we computed a map of the
native T=3 shell at 8 Å resolution (Fig. 1f). We
made a quasi-atomic model by docking in dimers
from the T=4 crystal structure,18 which ﬁt well in
the T=3 shell (Fig. 1g).
(a)
(f) (g)
(b)
(d)
(c)
(e)
Fig. 1. Structures of native HBV core shells. (a) T=4 map from EM12 with the crystal structure superimposed.18 (b and
c) Enlarged views from two directions of the dimer structure forming the spike. This is the A,B dimer (see below), which
forms rings around the 5-fold axes. The A chains are closest to the 5-fold axis while the B chains face outwards from it and
are closer to the 2-fold axis. The C,D spikes are positioned around the 2-fold axes. In (b), the MIR is shown in space-ﬁlling
representation, as deﬁned in Fig. 2. (d and e) Nomenclature for the structurally independent subunits A, B, C, and D in the
T=4 shell and A, B, and C in the T=3 shell, respectively.16 The rings represent the positions of the dimer spikes; 2, 3, and 5
indicate the positions of the icosahedral 2-fold, 3-fold, and 5-fold axes, respectively, and l3 denotes the local 3-fold axes. (f)
Electron microscope map of the T=3 shell with dimers from the crystal structure ﬁtted (see the text). This shell is 32 nm in
diameter. (g) Detailed view of the A,B dimer of the T=3 shell, showing good ﬁt of chain from the crystal structure.
65Structures of HBV Cores Presenting a Model EpitopeThe native T=3 core particle matches the T=4
particle in terms of the shape of the spikes and the
shape of density around the 3-fold and 5-fold axes.
The two types of T=3 spikes closely resemble theTable 1. Percentage of shells (T=3 or T=4) for various constr
CW full length CW trunc140 Riga full length
T=3 10 75 10
T=4 90 25 90
a From Borisova et al.29T=4 spikes, clearly exhibiting the bulbous knob‐
shaped proﬁle created by the crossing of the helices
at the dimer interface (see Fig. 1), as opposed to the
narrower conformation observed in mature T=4ucts
a Riga trunc144a S2-16 trunc144 S1-8 trunc144
20 60 80
80 40 20
66 Structures of HBV Cores Presenting a Model Epitopeviral cores.12 The A,B dimer from the crystal
structure of the T=4 shell (in the immature
conformation) docked precisely into the density of
the spike at the local 2-fold A,B position in the T=3
map. When the chains in the dimer were allowed to
dock independently, there was no signiﬁcant ad-
justment of the position or orientation of the
individual subunits. At the strict 2-fold C,C position,
the C-chain from the T=4 crystal structure ﬁtted
best. The level of differences between the conforma-
tions of the T=3 subunits themselves, and with the
four different T=4 solved chains, is within the
degree of variability of the four chains in the T=4
crystal structure.18
Constructs displaying the model epitope
Two different insertion constructs are studied
here, each containing the DPAFR epitope from the
preS1 region of hepatitis B surface protein. These
constructs, with a C-terminal truncation at position
144, were selected from a larger panel of 12
constructs that were characterized biochemically
and immunologically.29 They are named S2-16 and
S1-8. These two were chosen for structural analysis
because both were expressed and formed shells
relatively well, and competitive ELISA showed that
the inserted epitope was fully accessible to antibody.
The constructs differed in that when tested in mice,S1-8  ...TWVGGNLEDH
HBcAg ...TWVGNNLE  
         hhhhcccc  
S2-16 ...TWVGGNLEDH
             
(a)
h3
h5
h4a
h4b
(b)
Fig. 2. (a) Detailed structure of the subunit, shown rainbow
The fold that contributes to the spike consists of an outward‐go
4 is kinked midway, giving subhelices 4a and 4b. A short loop
ﬁrst few residues of helix 4a, forms the MIR (shown as space
with other epitopes. (b) Sequences in the region of the spike tip
The conformation of each residue (h for helical, c for coil) in th
sequence. The two constructs S1-8 and S2-16 used in this study
were characterized biochemically and immunologically.29 In
depending on strain) has been deleted and replaced by the epit
In the S2-16 construct, an additional 6 aa C-terminal to the nativ
in the native protein following helix 3 (GGNLE) has been ex
sequence DHDHV. The DPAFR epitope follows and joins ont
YVDH in S2-16. Hence, in both cases, the DPAFR epitope is ins
S2-16 has three and S1-8 has nine more amino acids than thethough both were immunogenic against the DPAFR
epitope, the strength of the immune response
induced to this epitope by the S2-16 construct was
10-fold higher than that of S1-8. The titer of the
antibody response was measured by direct ELISA
against preS1 peptide 21–47 containing the DPAFR
epitope, which showed that dilutions of sera of 103
for S1-8 but 104 for S2-16 took the optical absorbance
values down to background level. Background level
was determined as the mean of three measurements
of sera from non-immunized mice (see Table 2 of
Borisova et al.29).
In the native spike, the helical hairpin consists of
an outward‐going helix 3 and a returning kinked
helix 4, split into helix 4a and helix 4b at the kink
(Fig. 2a). The immunodominant native epitope
(DPASR or DPISR depending on viral strain) stands
exposed on the corner of the spike at the start of
helix 4a. In these two constructs, the native epitope,
DPISR, has been deleted and replaced by the
DPAFR epitope, inserted between two short linker
sequences (Fig. 2b). On the N-terminal side, the loop
following helix 3 is extended by a 5‐aa linker
sequence [linker 1 (L1), DHDHV]. The DPAFR
epitope follows and is joined to helix 4 by a 4‐aa
linker sequence [linker 2 (L2), YVDR or YVDH]. The
difference between S1-8 and S2-16 is that in S2-16,
the 6 aa of helix 4a following the native epitope
DPASR/DPISR have also been deleted. Thus, inDHVDPAFRYVDRDLVVSYVNTNMG...  n+9
       DPASRDLVVNYVNTNMG...   n
       chhhhhhhhhhhhchhh
DHV      DPAFRYVDHVNTNMG...  n+3
color coded, from N-terminus (blue) to C-terminus (red).
ing helix 3 and a returning helix 4 forming a hairpin. Helix
region of 5 aa joins helix 3 to helix 4 and, together with the
ﬁlling). This region at the tip of the spikes can be replaced
of the native and of the constructs with inserted epitopes.
e native crystal structure18 is indicated beneath the native
were selected from a larger panel of 12 constructs, which
these constructs, the native epitope (DPISR or DPASR
ope DPAFR from the preS1 region of HBV surface protein.
e epitope were deleted. In both constructs, the loop region
tended on the C-terminal side with a linker module, L1,
o another linker module, L2, sequence YVDR in S1-8 and
erted between the two linker modules, with the result that
native sequence.
67Structures of HBV Cores Presenting a Model Epitopethese constructs, S2-16 contains three more amino
acids and S1-8 contains nine more amino acids than
the native sequence. In the S1‐8 construct, the
foreign epitope and linker L2 might be expected to
extend from helix 4a in a helical conformation,
whereas in S2-16, the deletion would cause the
epitope to be embedded in helix 4a.
Comparison of the structures of the core particle
constructs
Images of the shells formed by the constructs
showed that the particles were predominantly of the
T=3 size, and there was a signiﬁcant number of
malformed or incomplete shells (Fig. S1). Good(a)
(c)
Fig. 3. Maps of T=3 core shells with inserted epitope. (a) S
native T=3 map superimposed in red. In each case, the region
the same radius as in the native construct. Around the 5-fold ax
native shell extends to higher radius, as indicated by the re
indicating that the spike in the S2-16 construct is shorter than
indicating that the spike in the S1-8 construct is longer than tparticles were selected from the micrographs and a
map of the T=3 shell for each of the constructs was
computed to 8 Å (Fig. 3a and b). The maps of the
modiﬁed cores displaying the model epitopes look
similar in overall character to the native T=3 core,
with well‐deﬁned helices forming the spikes, but
also show some clear differences, as outlined below.
The S1-8 map has longer spikes than the native
structure, while in the S2-16 map, the spikes are
shorter. When sections of the maps are viewed as
densities, each spike tip has a fuzzy weak density
around it, not observed in the native map, which
indicates that parts of the inserted sequences may
be disordered (see Fig. S2). Also, the spikes in the
modiﬁed cores are slender and narrow, resembling(b)
(d)
2-16. (b) S1-8. (c and d) The same maps in yellow with the
of the shell surface around the 3-folds (local 6-folds) lies at
es, the shell surface in the constructs has dropped, and the
d color at this position. In (c), the spike tips appear red,
that in the native, whereas in (d), the tips appear yellow,
hat in the native.
68 Structures of HBV Cores Presenting a Model Epitopemore closely those observed in the mature T=4
viral cores than those in the T=3 or T=4 cores of
the recombinantly expressed protein.12 The density(a)
(b)
(c)
Fig. 4 (legend onin the shell region (excluding the spikes) agrees
closely in most places, except that around the 5-fold
axes, the shell region of the construct maps has(d) (e) (f)
(g)
(h)
next page)
69Structures of HBV Cores Presenting a Model Epitopedropped to a lower radius (Fig. 3c and d). The
changes in conformation can be accounted for
largely by a bodily rotation of the subunit, but
some internal changes are also needed to fully
explain the differences.
When the atomic model of the T=3 core, obtained
by ﬁtting the subunits to the native T=3 map
(Fig. 4a), is overlaid on the construct maps (Fig. 4b
and c), the hairpin helices forming the spike do not
lie correctly in the density of either construct map.
It is apparent that the subunits need to be tilted to
ﬁt the helices into the map density (Fig. 4g and h),
which can be achieved quantitatively by docking of
the native core protein chains as individual sub-
units into the construct maps. The change in
conformation in the shell can be accounted for
mostly by a rigid‐body rotation of the subunits by a
few degrees about an axis roughly perpendicular
to the plane of the interface between the subunits of
the dimer. The effect is to reduce the crossover of
the helical hairpins from apposing dimers, resulting
in a narrower proﬁle of the spikes, much like that
observed in the T=4 cores obtained from mature
virions.12 The rotation (of ~6°) is largest for the A
chains, which are located in rings around each 5-
fold axis. These C-terminal helix 5s (Fig. 1b, c, e,
and f) associate in a ring around the 5-fold axis,
forming the shell layer at this position. The rigid‐
body rotation of the subunit, bringing the spike
helices into a more radial orientation, also has the
effect of pivoting the helix 5s about a point near the
base of the helices forming the hairpin, causing the
shell layer around the 5-fold axis to drop to a lower
radius (Fig. 3c and d). The subunit at the B position
rotates less and pivots about the C-terminal tip of
helix 5, leaving the shell radius unchanged here.
The subunits forming the spike at the C positions
also show a small rotation, also pivoting about the
C-terminal tips of helix 5, and achieving the more
slender spike proﬁle.
It is clear that though the ﬁt of the subunits into
the spike density of the constructs has improved
through rigid‐body reorientation of the subunits,
smaller additional changes are also needed to
explain the observed differences. In particular, theFig. 4. Spike conformations in the modiﬁed cores compare
symmetry axis showing the native T=3 map and atomic mode
model spike, same view as in (a). (c) Map of the S1-8 construct o
and (b). (d–f) Radial views of the tip of the spike, showing nati
shown, but the computationally independent A,B dimers in ea
additional bridging density seen in S1-8 (f) compared with w
averaging of noise. (g) S2-16 spike, same view as in (a) to (c), w
in the density. (h) S1-8 spike, same view as in (a) to (c), and (g),
ﬁtted fragment is shown in red and is the same fragment tha
aligned with the red fragment to show the improved ﬁtting in
fragment ﬁtted included helix 3 and helix 4b, but not helix 4a o
α-helix before helix 3 and beyond helix 4b was also included. (
constructs. (g) and (h) show how the change can be modeled la
the bridge of density joining the subunits in S1-8. (e) shows a douter segment of kinked helix 4 (helix 4a) needs to be
reoriented into density, predominantly as a rigid
body, but the exact position of the tip of helix 4a
cannot be certain from interpreting maps at this
resolution, though the strong density associated
with the spike structure is consistent with a helical
structure. The degree of tilt of helix 4a needed to ﬁt it
into the density in the outer region of the spike is
~20° for S2-16 and ~10° for S1-8. Since α-helices are
resolved as strong tubular densities in these maps at
8 Å resolution, the helices in the constructs can be
compared with those in the native core, and their
lengths can be estimated with an accuracy of one
turn of the α-helix (~3 or 4 aa). It is clear that helix 3
and helix 4a in the constructs show differences in
length compared with those in the native core. This
affects the position of the foreign epitope in the
constructs, as will now be described.
Positioning of the foreign epitope
The S2-16 spike appears to be a shortened version
of the native one (Fig. 4b and g). Helix 3 looks the
same length but helix 4a is shorter by ~1 turn
(Fig. 4b). (In the diagrams shown in Fig. 4, helix 4 of
the core protein subunit appears on the left and helix
3 appears on the right in the hairpin nearer to the
observer.) This is consistent with the fact that 2 aa
have been removed from within this helix and
suggests that the inserted linker sequence L2 must in
this case be mostly helical. The connection between
the unchanged helix 3 and the shortened helix 4
appears the same as in the native; hence, the 5‐aa
linker L1 added to the loop region does not form a
deﬁned density and is not seen. It probably gives
rise to the fuzzy weaker density apparent around
the spikes. In summary, in S2-16, L1 is disordered,
and L2 has been incorporated within helix 4 to
replace the deleted helical part of the native
structure. The DPAFR epitope is likely to adopt a
helical conﬁguration to replace the native DPASR/
DPISR epitope on the end of the shortened helix 4a.
In the map of the S1-8 construct, helix 4a also
appears about one turn shorter at its N-terminal end
compared with helix 4a in the native structured with the native type (wt). (a) Spike at the strict 2-fold
l. (b) Map of the S2-16 construct overlaid on the native T=3
verlaid on the native T=3model spike, same view as in (a)
ve (d), S2-16 (e), and S1-8 (f). In each case, the C,C dimer is
ch construct display very similar features. In particular, the
t (d) or S2-16 (e) is thus unlikely to have arisen from the
ith molecular fragment of spike, as shown, reoriented to ﬁt
with fragment of spike reoriented to ﬁt in the density. The
t was ﬁtted in (g). The larger fragment in gray has been
the extended part of helix 4a as well as the loop region. The
r the loop region between helix 3 and helix 4a. One turn of
b) and (c) show the mismatch of the native structure to the
rgely as a rigid‐body movement of the subunits. (f) shows
istortion compared to (d), but not the bridge shown in (f).
70 Structures of HBV Cores Presenting a Model Epitope(Fig. 4c and h), indicating that in this construct, the
inserted linker sequence L2 does not continue the α-
helix. Helix 3 appears to be extended by one turn.
The DPAFR epitope is positioned between the two
linkers L1 and L2. Since the S1-8 spike is longer than
the native spike, the linkers must extend outwards
from their constrained end points and present the
epitope at the tip of the extended spike. This is a
quite different conﬁguration to the native epitope or
to the foreign epitope in S2-16. The strong additional
feature in S1-8 at the tip of the spike lying across the
2-fold axis (Fig. 4f versus Fig. 4d and e) indicates
extra material and a new interaction between the(a)
(c)
Fig. 5 (legend onsubunits at the dimer interface. This compact
density may in part correspond to the inserted
DPAFR epitope forming a short helix. In the solution
structure of the preS1 protein from the HBV surface
antigen, a short region containing part of the DPAFR
epitope was shown to be helical.35 The fuzzy density
surrounding the spike indicates that there is some
disordered chain in this structure too (Fig. S2).
Thus, the sequence modiﬁcations at the tips of the
spikes cause entire subunits to undergo similar
rigid‐body rotations, giving rise to the similar
observed changes in the shell region of the structure.
The overall rigid‐body rotation of the subunits is(b)
(d)
next page)
71Structures of HBV Cores Presenting a Model Epitopealso responsible for the changes in the proﬁle of the
spikes, making themmore slender than in the native
shell. In addition, helix 4a reorients, causing or
caused by a reconﬁguration of the tip structure,
which is related to the overall subunit reorientation.
In both constructs, some of the inserted linker
sequence is disordered. The structure of S1-8 was
not as expected, since the inserted linker sequences
caused helix 3 to be extended rather than helix 4a.
Together with the additional partially ordered
material, this makes the S1-8 spikes longer than
those in the native structure. In the S2-16 construct,
the shortening of helix 4a and the disordering of the
loop at the tip make the spikes look shorter than in
the native structure.
Complexes of Fabs with the native core shell
An initial study of a complex of the well‐
characterized C1-5 antibody,36–38 which recognizes
the immunodominant DPISR epitope (more pre-
cisely 78-DPIxxD-83)38 at the tips of the spikes of
the native core shell, was made to allow compar-
ison with the interactions of the MA18/7 antibody
with the engineered core shells. Particles were
mainly (90%) of the larger T=4 form, and a map
of the T=4 complex computed to 8 Å resolution
gives an indication of the level of detail that can be
obtained in a favorable case. As this complex has
already been studied,27 only brief details are given
here to allow comparison with the constructs with a
foreign epitope.
The map of the complex (Fig. 5a) shows that the
diameter of the particle has increased from 350 Å for
the unlabeled core to 470 Å in the complex,
illustrating the large size of the antibody compared
to the spikes on core shell (see also Fig. S3). Because
the density for the fragment of antibodies (Fabs) is
weaker than that for the core (see below), the core
itself in the complex can be visualized by choosing a
density threshold intermediate between Fab and
core (Fig. 5b). The structure thus displayed closely
matches the uncomplexed core (Fig. 1a), as shown
by the good ﬁt of the crystal structure into the
density (Fig. 5b). Comparison of the map of theFig. 5. Map of the complex of C1-5 Fab with the native T=4
protein region of antibody complex. The Fab density is weake
due to blocking, and has been suppressed by setting the display
and the coordinates from the crystal structure (overlaid gray
associated Fab density (outlined with the broken line) with the
density adjacent to the epitope (shown as colored space ﬁlling)
the constant domain of the Fab. The surface of the core protein
complex with Fabs modeled in to show how the overall densi
blocking (see the text; Fig. S4). For clarity, the model represents
D sites. Fabs on A sites have their heavy and light chains color
green (heavy chain) and blue (light chain). Since the occupancy
Fabs on the C and D sites, the modeled Fabs ﬁll most of the obs
with annotation delimiting the shell region from bound Fabs.complex displayed at a lower density level (Fig. 5d)
with the view of the core shell (Fig. 5b) shows that
the Fabs form an additional outer shell of density
with twomain motifs, a turret-like nearly cylindrical
density on the 5-fold axis and a rectangular bridge of
density across the 2-fold (local 6-fold) axis. These
features represent superpositions of antibody frag-
ments bound to a subset of the icosahedrally related
sites. The computed map is icosahedrally averaged,
and at each position, the density represents the
average of the occupancy over all the symmetrically
related sites.
Examination of the additional density due to the
Fabs indicates that the four independent binding
positions on the A, B, C, and D subunits have
differing occupancies, demonstrating that their
environments are distinct from each other. Anti-
body binding at one site may block binding at
another site, as has been reported previously, for
example.39 In the core protein, the spike, being a
dimer, contains two closely positioned quasi-
equivalent antibody binding sites. The footprint of
binding of the Fab to one site overlaps with the
other; thus, only one of these can be occupied at
once, giving a maximum averaged occupancy level
of 50%, for all potential sites (Fig. S4). The Fabs
project off the epitope at the corner of the spike at
an angle of about 45° to the radius (Fig. 5c), as
observed previously.27 Because of this orientation,
the Fab fragments extend out sideways over a
relatively long distance and block access to binding
sites on neighboring spikes. The A chains are
arranged around the 5-fold axis, and their bound
Fabs face inwards towards the 5-fold axis, forming
the turret-like feature. The average occupancy for
the A site is 0.4, indicating that, on average, two of
the possible ﬁve A sites are ﬁlled. In the icosahed-
rally averaged map, this is represented as a partial
occupancy of 0.4 at all the sites, and the density at
the turret-like feature is an average of 2 Fabs per
5-fold motif, bound at random positions. Molecular
modeling (Fig. 5c and d and Fig. S4) indicates that a
maximum of two of these sites (of ﬁve potential A
sites) can be ﬁlled at once, in good agreement with
the measured occupancy.shell. (a) Central slice through Fab complex map. (b) Core
r than the core [see (a)], because of low occupancy of sites
surface at a high level. The core density is sharply deﬁned
tubes) ﬁt precisely. (c) Close‐up view of one spike and its
modeled Fv chain (drawn as a gray tube) docked into the
. The density more distant from the epitope corresponds to
[as in (b)] is indicated by mesh work. (d) Map of the whole
ty arises, although not all sites can be occupied because of
100% occupancy of A and C sites, with no labeling on B or
ed red or yellow, respectively. Those on C sites are colored
of the B sites is very low, and there is a large overlap of the
erved EM density. Figure S3 shows a section similar to (a),
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the 2-fold (local 6-fold) axes, where the three
different types of quasi-symmetry‐related sites (on
the B, C, or D chains), six in total, can clash, giving
rise to the bridge-like features. The occupancy at the
B site, B being the outward facing chain of the
dimers arranged around the 5-fold axis, was
measured as less than 0.1. This low occupancy can
be explained by the blocking effect of Fabs at the C
and D sites. The occupancy on the C and D chains
positioned around the local 2-fold axis was 0.4 and
0.2, respectively. The difference in occupancy at
these two similar sites could be due to their different
structures or environments—which is a conse-
quence of the quasi-symmetry. The orientation of
Fab binding and separation of spikes on the core
appear to be compatible with bivalent binding of
an antibody.
Fab complexes with the modified core shells
containing inserted epitopes
The core shell constructs were labeled with Fabs
derived from the monoclonal antibody MA18/7 to
the DPAFR epitope. The maps of the labeled S2-16
complex are similar in character to the C1-5‐
labeled native complex. Figure 6a and b show
equivalent views of T=4 maps of the native and
S2-16 Fab complexes, at the same nominal
resolution of 15 Å. The Fabs project out from the
spikes at a similar angle to form similar motifs at
the 5-fold or 2-fold symmetry axes. Slight orienta-
tion differences could be due to the different
nature of the interaction in the two complexes, as
well as the epitope being presented differently. In
addition, it is possible that the two different
antibodies (C1-5 and MA 18/7) exhibit slightly
different elbow angles.40 However, the major axis
of corresponding Fabs lies in a very similar
direction and thus gives rise to very similar
maps. Since they are so similar, it is very likely
that the position and orientation of presentation of
the epitopes are very similar and that the model
epitope has essentially replaced the native epitope
at the top of helix 4.
Cross-reactivity of the antibodies has been tested
in Western blot, direct and competitive ELISA, and
immunogold EM (P.P. et al., unpublished results).
The anti-DPAFR MA18/7 antibody does not cross-
react with the native DPASR or DPISR core epitope
in Western blot, ELISA, or immunogold EM. No
sign of even weak reaction was ever seen. Vice
versa, the C1-5 antibody does not recognize S1-8, S2-
16, other HBc (core protein from HBV) VLP carriers
bearing the DPAFR epitope and lacking native
DPISRD sequence, or RNA phage coat protein-
preS1 fusions, which contain DPAFR epitope in
different amino acid neighborhood (P.P. et al.,
unpublished results).Comparison of the T=4 and T=3 S2-16 maps
(Fig. 6b and c), which have identical Fab binding at
the molecular level, illustrates how the same
features manifest differently according to the differ-
ent T=3 or T=4 packing. The turret‐like motifs
around the 5-fold axes correspond closely, but in the
T=3 structure, the bridge across the local 6-fold axis
has strict 3-fold symmetry, as opposed to having
strict 2-fold symmetry in the T=4 structure. Apart
from the symmetry difference, these bridges are
similar in character.
Since the majority of the S1-8 particles were of
the T=3 type, only a T=3 map of the S1-8 Fab
complex was calculated. In Fig. 6c and d, the S2-16
T=3 map is compared with the S1-8 T=3 map.
The additional density due to the Fabs in the
S1-8 map extends radially outwards from the
spikes on the shell, rather than at an angle (~45°)
as for the S2-16:MA18/7 Fab or native core:C1-5
Fab complexes. The S1-8:MA18/7 Fab map does
not show the same motifs as the native core:C1-5
Fab or S2-16:MA18/7 Fab maps on the 5-fold or
3-fold axes. Because of the radial disposition of
the Fabs in the S1-8 complex, the density due to
Fabs is less distinct than for the S2-16 complex, as
it does not form the distinctive “bridges” or
interacting motifs across the symmetry axes.
Thus, blocking between sites on adjacent spikes
does not occur, and the blocking effect is
restricted to the overlap of the two closely spaced
sites on the tip of a given spike.
The Fab density on S1-8 is strongest near the tips
of the spikes on the core shell. It becomes weaker
with increasing distance from the surface, indicating
a level of ﬂexibility or disorder. The density lying
close to the dimer interface (2-fold axis for C,C spike,
or local 2-fold for A,B spike) is enhanced by 2-fold
averaging (computational 2-fold averaging at the C,
C spike, or superposition of quasi equivalent
densities on the A,B spike). This combination of
disorder and 2-fold averaging makes it difﬁcult to
interpret the outer density in detailed terms of the
shape of a Fab.
An additional density feature observed at the tip
of the spike in the S1-8 unlabeled core (Fig. 4f)
indicates that the DPAFR epitope lies close to the
2-fold or local 2-fold axes at the tip of the spike of
the dimer in the S1-8 construct. This explains why
the DPAFR epitope on S1-8 is accessible, though in
a very different environment to S2-16. It also raises
the possibility of interference of the two epitopes
on the dimer with one another, since they are in
close proximity. The location of the epitope in an
unconstrained position in a loop at the tip of the
spike may also explain why in this complex the
Fab fragments do not appear well ordered. Since
S1-8 and S2-16 contain exactly the same epitope,
the different levels of immunogenicity observed in
mice must be due to the way it is presented.
(a) (b)
(c) (d)
Fig. 6. Maps of various complexes of Fabs and core shells. (a) T=4 native shell with C1-5 Fab (as Fig. 5a and d, but at
lower resolution to compare with construct maps). (b) T=4 S2-16 construct with MA18/7 Fab. (c) T=3 S2-16 construct
with MA18/7 Fab. (d) T=3 S1-8 construct with MA18/7 Fab. Note that the maps in (a), (b), and (c) have a similar
character, with the Fabs coming together to make strong features around the symmetry positions [5-fold and 2-fold in
(a) and (b); 5-fold and 3-fold in (c)], whereas in (d), the density arising from the Fab is radial and does not create
features around the symmetry axes. The maps were ﬁltered to 15 Å resolution. The radial color scales shown are
calibrated in angstroms (Å). The core shell is colored yellow, and then the color graduates in 20‐Å bands from green, to
light blue, to dark blue as the radius increases. The outer limit of the shell radius is 160 Å or 175 Å for the T=3 or T=4
shells, respectively.
73Structures of HBV Cores Presenting a Model EpitopeIn summary, in S2-16, the model epitope is in a
position and conformation closely resembling the
immunodominant epitope in the native shell. Bound
Fabs project from the “corner” of the spike, at an
angle of ~45°, causing blocking effects between sites
on different spikes. In S1-8, the DPAFR epitope is
located more centrally on the tip of the spikes, near
the dimer interface and the 2-fold axis. The density
of bound Fabs projects radially outwards from the
center of the spike. No blocking between sites on
different spikes will occur with this geometry. The
footprint of antibody binding will only allow oneantibody or Fab to bind per spike on either of the
constructs or to the MIR on native cores.Conclusions
HBV core protein has an inherent and complex
immune stimulating capability,10 which is both T-
cell independent and T-cell dependent.41 The native
core protein assembled into particles can present
many copies of an epitope with high density and
appropriate spacing to cross-link B‐cell receptors
74 Structures of HBV Cores Presenting a Model Epitopeoptimally.42 For the native particle, this produces a
strong antibody response against the major immu-
nodominant epitope positioned at the tips of the
spikes on the core shells. By removing the native
immunodominant epitope and inserting a foreign
sequence in its place, it is possible to elicit a strong
immune response to the inserted sequence. The
inserted sequence may be a large protein domain or
just a small peptide. In the latter case, as we have
studied here, the exact positioning of the foreign
sequence can have large effects on the immunoge-
nicity of the construct.
For the modiﬁed core construct to induce an
effective immune response, the displayed foreign
epitope must be able to bind strongly to receptors
on B-cells in a way that promotes the cross-linking
of clustered receptors. The structure of the MIR at
the tips of the HBV core protein spikes potentially
allows the inserted epitope to be either displayed as
a loop constrained at both ends by ﬁxed α-helices in
the hairpin or incorporated in a helical conforma-
tion at the end of one of the radially extending
helices. The two constructs studied here appear to
exemplify these two modes of display. Small
changes in the construct, for example, in the number
of amino acids in the insert, can have large effects on
the orientation and accessibility of the epitope. If the
epitope is embedded in an α-helix, then a change of
one amino acid position in the sequence can cause
the epitope to be reoriented by 100°. In addition,
changes made to the core protein around the MIR
cause a change in orientation of the subunits in the
dimer forming the spikes on the exterior of the core
shell and this may affect the orientation and
accessibility of the epitope presented.
In the S2-16 construct studied here, the inserted
foreign epitope appears to be positioned in a partly
helical conformation that closely mimics that of the
native immunodominant core epitope. The binding
of antibodies C1-5 and MA18/7, respectively, to the
two kinds of shell is very similar, with the Fab
fragments projecting off the “corners” of the spikes
at an angle of ~45° to the radius. This overall
arrangement is therefore likely to be a favorable one
for strong interactions between core shell and
membrane‐bound B‐cell receptors, exploiting an
equivalent geometry. Like the native core protein,
S2-16 might therefore be expected to produce a
strong immune response, as indeed it does.29 In the
S1-8 construct, by contrast, the foreign epitope
appears to be displayed as a less ordered feature
right at the tip of the spike and the bound Fab
fragment lies in a radial direction. This Fab
arrangement may indicate a much less favorable
geometry for interaction of the foreign epitope with
the equivalent arm of a membrane‐bound B‐cell
receptor, leading to less efﬁcient cross-linking and a
correspondingly weaker immune response than that
observed against S2-16.29 In addition, in S1-8, theepitope is presented exposed near the 2-fold axis
right at the tip of the dimer spike. This might allow
interactions with the partner epitope from the other
member of the dimer to change the molecular
surface presented. In the S2-16 construct, this
could not occur. There is also the question of
whether a small inserted sequence in the engineered
core adopts a conformation like that of the epitope in
the context of its native protein. In our case,
monoclonal antibody MA18/7 was raised against
native surface antigen,30 and since both S1-8 and
S2-16 react with MA18/7 and, in mice, induce
production of antibodies that react with the native
preS1, they must both be displaying the DPAFR
epitope in something close to its native conforma-
tion. However, in S2-16, the epitope is embedded
in the native-like α‐helix 4a, which may have a
stabilizing effect on its conformation. This more
rigid and deﬁned location and environment may
also favor stronger interactions with the mem-
brane‐bound B‐cell receptors. The organization of
the linkers in S1-8 does not provide the same level
of constraint. Different modes of insertion may
have different constraints, and it may be that the
SplitCore approach,43 which provides a less con-
strained setting, will prove advantageous especial-
ly for larger domain inserts.
Therefore, in the design of virus-like particles for
use as vaccine carriers, it is important to consider the
three‐dimensional (3D) structure of the entire
particle. Since core particles carrying preS1 epitopes
are considered as a prospective therapeutic vaccine
against chronic hepatitis B,2 our data may help in
this particular case. The overall conformation
changes in the spikes observed for the two different
constructs were similar; hence, this information
could be used when designing constructs with
other epitopes. However, especially since the core
particles are not strictly rigid scaffolds to which the
epitopes become attached and it is also hard to
predict the conformation that will be adopted by
any particular inserted sequence, it will help to
visualize the structures of further constructs and
relate them to the results of functional assays.Materials and Methods
Production of core shells
Cloning, expression, and puriﬁcation of the HBV core
particles S1-8 and S2-16 with DPAFR epitope inserted at
the MIR were performed as previously described.29
Brieﬂy, E. coli K802 (hsdR, gal, met, supE, mcrA, mcrB)
cells were grown overnight on a rotary shaker at 37 °C in
750‐ml ﬂasks containing 300 ml of M9 minimal medium
supplemented with 1% casamino acids (Difco Laborato-
ries, USA) and 0.2% glucose. An OD540 (optical density at
540 nm) of 2–5 was usually reached. Cells were pelleted
75Structures of HBV Cores Presenting a Model Epitopeand lysed by 30‐min incubation on ice in lysis buffer
containing 50 mM Tris–HCl, pH 8.0, 5 mM ethylenedia-
minetetraacetic acid, 50 μg/ml PMSF, and 2 mg/ml
lysozyme, and then ultrasonicated 3 times for 15 s at
22 kHz. Lysates were adjusted to 10 mM MgCl2 and
20 μg/ml DNase and after 5‐min incubation to 0.1 M urea.
After low‐speed centrifugation, proteins were precipitated
from the supernatant with ammonium sulfate at 33%
saturation for 1–2 h at 4 °C. Ammonium sulfate pre-
cipitates were washed with phosphate‐buffered saline
(PBS) buffer and then dissolved in PBS containing 1.5 M
urea and 0.6% Triton X-100 just before loading onto the
Sepharose CL4B column (2.5 cm×85 cm). The S1-8 and
S2-16 capsids were eluted from the column with PBS
buffer containing 0.25 M urea and 0.01 % Triton X-100.
The presence of S1-8 and S2-16 polypeptides in
fractions was tested by PAGE. Positive fractions were
pooled and concentrated by ammonium sulfate precip-
itation at 33% saturation for 20 h at 4 °C. Pellets were
resuspended in PBS or in Tris–saline buffer—10 mM
Tris–HCl, pH 7.5, and 150 mM NaCl—to a ﬁnal concen-
tration of about 2 mg/ml, dialyzed overnight against
2000 volumes of the same buffer, and stored at −70 °C
in 50% glycerol.
The native T=4 particles for labeling with the C1-5
antibody were prepared exactly as described previously,
for the full‐length CW isolate.12 For isolation of T=3
particles, the construct HBcΔ-CW, in which the core
protein is truncated after amino acid 149,44 was subject to
a further truncation after amino acid 140. This was
produced by PCR using oligonucleotide primers 5′ GA
CTT CAA CAT ATG ACA TTG ATC CTT ATA AAG 3′
and 5′ CCG GAA TTC TCA TAA GAT AGG GGC ATT
TGG 3′. The resulting PCR product was cleavedwith NdeI
and EcoRI and inserted into the corresponding restriction
sites in the expression plasmid PT7-SC. Preparation of
T=3 shells was then done in the same way as for T=4
shells,44 but with the modiﬁcation that in the ﬁnal sucrose
gradient centrifugation step, the later fractions of the peak
were selected.
Antibody labeling
Fabs from the C1-536 or MA18/730 antibodies were
prepared by digestion with Papain,45 using Pierce Kit
44885 (Thermo Fisher Scientiﬁc, Cramlington, UK).
Antibody fragments were mixed with core shells, at a
ratio of ~1 Fab per HBV core dimer, before freezing on
EM grids.Electron cryomicroscopy
Samples of core shells, or antibody complexes, were
prepared for EM on holey carbon ﬁlms, by standard
methods.12,17 Frozen hydrated samples were imaged at
300 kV or 200 kV, with a nominal magniﬁcation of
50,000×, on an FEI Tecnai F30, or F20, or 60,000× on a
Hitachi HF-2000 electron microscope. Images were
recorded on Kodak SO-163 ﬁlm and developed in full‐
strength Kodak D19 for 12 min. Filmswere digitized using
a Zeiss SCAI Scanner (Z/I imaging, Oberkochen),
sampling at 7 μm per pixel. Two-by-two pixel binning
was then applied, giving a resultant 14 μmper pixel. TableS1 shows a summary of imaging conditions and param-
eters for each structure analyzed.Image analysis and 3D reconstruction
Image processing, 3Dmap computation, and reﬁnement
of the magniﬁcation were performed as before,12 using the
MRC programs for icosahedral reconstruction.46,47 Parti-
cles were selected manually using Ximdisp48 or automat-
ically using FindEM.49 The sampling for the images of the
non-native‐labeled particles was reduced by a further
factor of 2 by binning adjacent pixels. SPIDER50 pro-
cedures were used for iterative alignment and centring of
particles. Imagic51 was used for multivariate statistical
analysis and classiﬁcation of the aligned particle sets. A
signiﬁcant portion of the non-native core particles suffered
frompoor assembly. Classes of particles forming complete,
nondeformed shells were selected visually. These classes
appeared unbroken and isometric. The common‐lines
procedure47 was used to ﬁnd the orientation of the
particles directly from the class averages. The four or ﬁve
best scoring class averages were used to reconstruct an
initial 3D model. After this, individual particles from the
selected classes were reﬁned iteratively against projections
of the current best 3D model, as before.11,12,17 Initially, the
defocus used to ﬁt a contrast transfer function for each
image was determined from the summed power spectra of
the particles.17 The contrast transfer function was reﬁned
iteratively in the ﬁnal stages of the reconstruction
procedure.12 Finally, the maps of unlabeled cores were
sharpened by weighting the Fourier amplitudes so as to
match the rotationally averaged one-dimensional ampli-
tude proﬁle with the atomic model of the T=3 shell (as
ﬁtted), as previously described.12 Maps of unlabeled cores
were reliably determined to 8 Å resolution (Fig. S5), as
deﬁned by the Fourier shell correlation criterion 0.33.52 The
maps of Fab labeled cores were determined to beyond
15 Å, or 8 Å in the case of the native core:C1-5 Fab complex
(Figs. S6 and S7. The ﬁnal maps of unlabeled cores and the
native core:C1-5 Fab complex were limited to 8 Å
resolution by Fourier truncation for analysis, comparison,
and display. The Fab complexes of S2-16 and S1-8 were
similarly limited to 15 Å for analysis and display. The hand
of the native T=3 and T=4 maps was assigned directly
based on the distinctive handed motifs seen at the 5-fold
axis (since the atomic model for T=4 was available). The
hand of the other, lower‐resolution, maps could be
assigned based on comparing coarser handed features
with the known T=3 and T=4 maps.
Docking and modeling
DockEM53 was used to ﬁt models and fragments into
3D maps. A magniﬁcation search with atomic models and
the EM maps was used to determine the magniﬁcation of
the EM maps accurately. A modiﬁcation of DockEM, to
restrict searches to rotations about a speciﬁed pivot point,
was implemented for ﬁtting of helix fragments. T=3 quasi-
atomic model: The chains from the crystal structure of the
T=4 shell18 were ﬁtted as dimers, and as individual
chains, into all three unique positions in the T=3 map,
using DockEM. For docking, a density was created from
the atomic models and ﬁltered to match the resolution of
76 Structures of HBV Cores Presenting a Model Epitopethe EM map, 8 Å. Once a preliminary ﬁt of the dimer had
been obtained, the relative magniﬁcation was optimized
by including a relative scale in the local search to match
the dimer in the density.
A full atomic model of the T=3 shell was created by
applying icosahedral symmetry to the ﬁtted chains at the
A,B and C,C spikes, using the CCP454 program PDBSET.
A density map created by ﬁltering this model to 8 Å was
used to optimize the magniﬁcation scale of the other T=3
core shell maps, by correlation in DockEM. A scale search
repeated using the native T=3 EM map, or a density
model from the coordinates created with the tips of the
spikes deleted, produced the same results.Modeling of core
particles with DPAFR epitope inserted: Superposition of the
maps indicated changes in shell region and tips of spikes.
Superposition of the native T=3 model and maps of the
modiﬁed core particles also demonstrated changes.
Initially, changes at the tip were not modeled due to the
weaker less deﬁned density in this region. A series of
fragments of the subunit, excluding tip region, were
created and docked into the density. It was found that
changes in the shell domain could be modeled as rigid‐
body reorientations of the subunit structure. The tip
changes were modeled by docking of small helical
segment representing helix 4a to the existing ﬁtted
model. The extension of helix 3 in the S1-8 map was
examined by superpositioning a model helix to extend
from the tip of helix 3. Fragment of antibody variable domain
(Fv) docking and occupancy analysis:An atomic model of the
core particle antibody complex was obtained by docking a
model of the Fv of antibody C1-5 into the map density,
using information to 8 Å resolution. The docking of the Fv
at the density associated with chain C proved the most
reliable, due to a combination higher occupancy and less
superposition effect than the A site. Symmetry‐related
positions on the other three chains were obtained by
applying the quasi-symmetric relationships of the under-
lying chains. This enabled a full atomic model of the core
shell Fv complex to be obtained. The atomic model of the
C1-5 Fv was obtained by submitting the sequence37 to the
Web Antibody Modeling server.55
A model of the core shell with complete Fabs bound
was obtained using an antibody model chosen to have a
compatible elbow angle40 with the density observed,
selected from the Protein Data Bank (Protein Data Bank
code: 1DBA). The Fv region of this model was aligned to
the positioned C1-5 Fv models. The occupancy levels at
all the different sites were determined by creating a
simulated density from the atomic model of this complex,
for all permutations of occupancy, in steps of 10%. The
simulated densities were correlated with the observed
EM map of the complex using DockEM,53 using
information to 15 Å resolution, with the best match
indicating the correct occupancy. On the scale used, the
maximum possible occupancy per binding site on each
chain is 1. However, because only 1 of the 2 sites per
dimer can be occupied, the maximum possible occupancy
for C+D or A+B is 1; that is, if there was 100% C site
occupancy, then no D sites could label. Therefore, if the
A,B and C,D spikes were 100% labeled (i.e. one Fab per
spike), then the total occupancy of all the sites would add
up to 2. Atomic coordinate alignments and transforma-
tions were computed using Amira Software (Visage
Imaging GmbH, Berlin, Germany), as were map render-ing and molecular representations for Figs. 1–5. Figure 6
was made using UCSF Chimera.56Acknowledgements
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